News & Updates

Patients who wait a longer time before receiving their transcatheter aortic valve replacement (TAVR) procedures face higher 1-year mortality rates post-operation, a recent study has found.

Using the antifibrinolytic tranexamic acid (TXA) during noncardiac surgery significantly reduces bleeding without significant increases in vascular complications in patients at risk for these complications, according to the POISE-3* trial presented at ACC 2022.

The use of the electronic health record (EHR) to provide timely, personalized clinical decision support alerts can improve the adoption of guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) in the outpatient setting, as shown in the results of the PROMPT-HF trial presented at the American College of Cardiology (ACC) meeting.

Incident cognitive impairment seems higher among older adults with high waist circumference (WC) and low calf circumference (CC), suggests a study.

The humanized IgG4 monoclonal antibody tislelizumab was clinically active in women with gynaecologic microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) solid tumours, and was generally well-tolerated with no new safety signals, according to a subgroup analysis of the phase II RATIONALE 209 study presented at SGO 2022.